• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Genzyme

Related Topics

  1. USAA Large Value
  2. USAA Large Growth
  3. USAA Large Blend
  4. JA Solar Holdings
  5. Fidelity Large Value
  6. Fidelity Small Value

Popular Topics

  1. Eagle Bulk Shipping
  2. Smartphones
  3. Credit Ratings
  4. Regulation
  5. Seabridge Gold

Genzyme

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Genzyme Corporation GENZ Q1 2010 Earnings Call Transcript

    Welcome to the Genzyme Corporation s First Quarter Financial Results Conference Call. All parties will be in a listen-only mode until the question-and-answer session. (Operator Instructions). Also, this call is being recorded. If you have any objections, you may disconnect at this time.

  2. Genzyme Corporation GENZ Q4 2009 Earnings Call Transcript

    Good day, and welcome to the Genzyme Corporation s Fourth Quarter Financial Results Conference Call. All participants will be in a listen-only mode until the question-and-answer session. (Operator Instructions). Also this call is being recorded. If you have any objections you may disconnect at this time. I would like to turn the call over now to Mr. Patrick Flanigan, Senior Director of Investor Relations. Sir, you may begin.

  3. Genzyme Corporation GENZ Q2 2010 Earnings Call Transcript

    Welcome to the Genzyme Corporation's Second Quarter Financial Results Conference Call. All participants will be in a listen-only mode until the question-and-answer session. (Operator Instructions). Also, this call is being recorded. If you have any objections, you may disconnect at this time. I would like to turn the call over now to Mr. Patrick Flanigan, Senior Director of Investor Relations. Sir, you may begin.

  4. Genzyme Corporation GENZ Q3 2010 Earnings Call Transcript

    Welcome to the Genzyme Corporation's Third Quarter Financial Results Conference Call. All participants will be in a listen-only mode until the question-and-answer session. (Operator Instructions). Please limit your questions to one. Also, this call is being recorded. If you have any objections, you may disconnect at this time.

  5. Research and Markets: PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022

    Research and Markets: PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022

  6. Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global Consolidation

    Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global Consolidation

  7. 89 Degrees Names Bill Peña Vice President of Technology Services

    89 Degrees Names Bill Peña Vice President of Technology Services

  8. Genzyme Corporation WFC Q2 2010 Earnings Call Transcript

    Welcome to the Genzyme Corporation's Second Quarter Financial Results Conference Call. All participants will be in a listen-only mode until the question-and-answer session. (Operator Instructions). Also, this call is being recorded. If you have any objections, you may disconnect at this time. I would like to turn the call over now to Mr. Patrick Flanigan, Senior Director of Investor Relations. Sir, you may begin.

  9. Isis Pharmaceuticals Earns $3.5 Million from Biogen Idec

    Isis Pharmaceuticals Earns $3.5 Million from Biogen Idec

1234
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.